SRF delivered a strong performance in Q1FY27 propelled by robust growth in all the key business verticals. Revenue, EBITDA and PAT grew by 32%, 49% and 76% respectively. The Chemicals business registered a growth of 26% YoY and EBIT growth of 27% YoY led by strong Ref-Gas pricing as well as higher volumes across domestic and exports markets. In terms of Specialty Chemicals business positive demand trends have been seen in set of core products in volumes as well as prices. The recovery in the agrochemical segment is expected...